Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder
Maria Pia Giannoccaro,1,2 Rocco Liguori,1,2 Giuseppe Plazzi,1,3 Fabio Pizza1,2 1IRCCS Istituto delle Scienze Neurologiche di Bologna, Ospedale Bellaria, Bologna, Italy; 2Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy; 3Department of Biomedical, Metabolic and...
Guardado en:
Autores principales: | Giannoccaro MP, Liguori R, Plazzi G, Pizza F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bdde7840cb7641a09c00e9ab522232a0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Update on the treatment of narcolepsy: clinical efficacy of pitolisant
por: Calik MW
Publicado: (2017) -
Creativity in Narcolepsy Type 1: The Role of Dissociated REM Sleep Manifestations
por: D'Anselmo A, et al.
Publicado: (2020) -
The Association Between Asthma and Narcolepsy: A Nationwide Case-Control Study in Taiwan
por: Chen TY, et al.
Publicado: (2021) -
Immune-mediated comorbidities in Saudi patients with narcolepsy
por: Alomar M, et al.
Publicado: (2019) -
New developments in the management of narcolepsy
por: Abad VC, et al.
Publicado: (2017)